AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator By: MarketWatch May 25, 2021 at 07:24 AM EDT The deal has already been approved by the U.S. and Canadian authorities. Read More >> Related Stocks: Alexion Pharmaceuticals